Diabetes, Vol 47, Issue 1 32-38, Copyright © 1998 by American Diabetes Association

ARTICLES

Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats

F Nicoletti, P Zaccone, R Di Marco, G Magro, S Grasso, F Stivala, G Calori, L Mughini, PL Meroni and G Garotta
Institute of Microbiology, University of Milan, Italy. fnicol@herganet.it

Previous studies have shown that anti-gamma-interferon (IFN-gamma) antibody reduces the frequency of autoimmune IDDM in the DP-BB rat. We tested the effects of systemically administered recombinant rat IFN-gamma in both DP-BB and DR-BB rats. Unexpectedly, IFN-gamma markedly reduced the incidence of IDDM as compared with control rats when administered six times per week at a dosage of 280,000 U between ages 30-35 to 105 days or ages 60-64 to 105 days. A lower dosage (28,000 U on alternate days) was also protective when administered to DP-BB rats between birth and age 60 days. However, long-lasting protection against IDDM development over the 1-year study period was achieved only by the highest dosage of IFN-gamma administered from age 30 to 105 days. Ex vivo production of tumor necrosis factor-alpha from splenic lymphoid cells (SLCs) and peritoneal macrophages of the rats treated with IFN-gamma was comparable with that of controls; however, SLCs from the IFN-gamma-treated animals secreted lower amounts of IFN-gamma after stimulation with concanavalin A. IFN-gamma treatment also markedly reduced the frequency of phenotypically activated SLC-expressing class II antigens and interleukin-2 receptor. Finally, in agreement with the observed antidiabetogenic effects, exogenously administered IFN-gamma induced neither insulitis nor IDDM development in DR-BB rats, a subline of DP-BB rats in which autoimmune diabetes rarely occurs spontaneously but can be induced by administration of polyinosinic-polycytidilic acid.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. A. Saunders, T. Raine, A. Cooke, and C. E. Lawrence Inhibition of Autoimmune Type 1 Diabetes by Gastrointestinal Helminth Infection Infect. Immun., January 1, 2007; 75(1): 397 - 407. [Abstract] [Full Text] [PDF]

				C. O. Jacob, S. Zang, L. Li, V. Ciobanu, F. Quismorio, A. Mizutani, M. Satoh, and M. Koss Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice J. Immunol., August 1, 2003; 171(3): 1564 - 1571. [Abstract] [Full Text] [PDF]

				F. J. Quintana, A. Rotem, P. Carmi, and I. R. Cohen Vaccination with Empty Plasmid DNA or CpG Oligonucleotide Inhibits Diabetes in Nonobese Diabetic Mice: Modulation of Spontaneous 60-kDa Heat Shock Protein Autoimmunity J. Immunol., December 1, 2000; 165(11): 6148 - 6155. [Abstract] [Full Text] [PDF]

				G. Papaccio, F. Nicoletti, F. Aurelio Pisanti, K. Bendtzen, and M. galdieri Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in Vitro Antigen-Pulsed Syngeneic Dendritic Cells Endocrinology, April 1, 2000; 141(4): 1500 - 1505. [Abstract] [Full Text] [PDF]